DVA - DaVita Inc.
| Previous Close | 58.36 |
| Open | 58.00 |
| Bid | 0.00 x 800 |
| Ask | 63.00 x 2200 |
| Day's Range | 57.51 - 58.36 |
| 52 Week Range | 43.40 - 79.11 |
| Volume | 8,253,741 |
| Avg. Volume | 2,651,615 |
| Market Cap | 9.269B |
| Beta (3Y Monthly) | 2.11 |
| PE Ratio (TTM) | 71.12 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
DaVita Announces Preliminary Results Of Self-Tender Offer
DENVER, Aug. 19, 2019 /PRNewswire/ -- DAVITA INC. (DVA), "DaVita," a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe and the largest provider of kidney care services in the U.S., announced today the preliminary results of its modified "Dutch auction" tender offer for up to $1.2 billion of its common stock at a price per share not less than $53.50 and not more than $61.50, which expired at 12:00 midnight, New York City time, at the end of the day on August 16, 2019. Based on the preliminary count by the depositary for the tender offer, a total of 21,969,132 shares of the Company's common stock were validly tendered and not validly withdrawn at or below the price of $56.50 per share, including 13,467,338 shares that were tendered through notice of guaranteed delivery.
- PR Newswire
DaVita Announces New Senior Secured Credit Agreement
DENVER, Aug. 12, 2019 /PRNewswire/ -- DAVITA INC. (DVA) ( "DaVita" or the "Company"), a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe and the largest provider of kidney care services in the U.S., announced today that it has entered into a new $5.5 billion senior secured credit agreement, dated as of August 12, 2019, with the guarantors party thereto, the several banks and other financial institutions or entities party thereto, and Wells Fargo Bank, National Association, as administrative and collateral agent (the "New Credit Agreement"). The New Credit Agreement consists of a five-year secured revolving loan facility in an aggregate amount of $1.0 billion, a five-year secured term loan A facility with a delayed draw feature in an aggregate amount of $1.75 billion and a seven-year secured term loan B facility in an aggregate amount of $2.75 billion.
- PR Newswire
DaVita Inc. 2nd Quarter 2019 Results
DENVER , Aug. 1, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2019. Second quarter 2019 financial highlights: Completed the sale of our DMG division ...
- PR Newswire
Innovation in Home Care Delivery Improves the Quality of Life for More Kidney Patients
DENVER, July 30, 2019 /PRNewswire/ -- DaVita Kidney Care, a leading provider of kidney care services in the United States, announced today that growth of its peritoneal dialysis and home hemodialysis programs is four times the growth rate of in-center treatment options.* This comes on the heels of DaVita's success with its new Home Remote Monitoring program that allows patients to consistently share clinical information with their care team. The company's home growth rate is also a testament to the engagement and support for appropriate home dialysis among its physician leaders. "This is a transformational time in U.S. health care—one where the consideration and acceptance of home-based treatments is higher than I've seen in the 30 years I've been part of the medical community," said Dr. Martin Schreiber, chief medical officer for Home Dialysis at DaVita Kidney Care.
- PR Newswire
DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock For An Aggregate Purchase Price Of No More Than $1.2 Billion At A Purchase Price Of Not Less Than $53.50 Per Share And Not More Than $61.50 Per Share
DENVER, July 22, 2019 /PRNewswire/ -- DAVITA INC. (DVA), "DaVita," a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe and the largest provider of kidney care services in the U.S., announced today that it has commenced a modified "Dutch auction" tender offer for up to $1.2 billion of its common stock at a price per share not less than $53.50 and not greater than $61.50. The tender offer will expire at 12:00 midnight, New York City time, at the end of the day on August 16, 2019, unless extended by DaVita or otherwise terminated. Tenders of shares must be made on or prior to the expiration of the tender offer and may be withdrawn at any time prior to the expiration of the tender offer, in each case, in accordance with the procedures described in the tender offer materials.
- PR Newswire
DaVita Inc. Announces Preliminary Second Quarter 2019 Results and Updated Guidance for Fiscal Year 2019
The Company is releasing this information to provide investors with updated financial information in conjunction with its anticipated modified "Dutch auction" tender offer for up to $1.2 billion of its common stock at a price per share not less than $53.50 nor greater than $61.50.
- PR Newswire
DaVita Inc. Schedules 2nd Quarter 2019 Investor Conference Call
DENVER , July 22, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States and in 9 countries around the world, announced today that it will hold its ...
- PR Newswire
DaVita Statement on Advancing American Kidney Health
DENVER, July 10, 2019 /PRNewswire/ -- DaVita Kidney Care appreciates President Trump, the Administration and Secretary Azar for taking steps to improve the lives of kidney patients. "DaVita is encouraged that this Administration has taken steps toward holistic, value-based care for kidney patients.
- Business Wire
Optum Completes Acquisition of DaVita Medical Group from DaVita
Optum, a leading health services company, completed its acquisition of DaVita Medical Group, one of the nation’s leading independent medical groups, from DaVita Inc. (DVA). As part of the transaction, HealthCare Partners Nevada, DaVita Medical Group’s primary care practice in southern Nevada, will become part of Intermountain Healthcare. DaVita Medical Group joins OptumCare, which serves more than 80 health plans, and will provide quality care to a combined 16 million patients.
- PR Newswire
DaVita Reports on 2018 Corporate Social Responsibility Initiatives
Company highlights achievements in patient care, community growth and sustainability DENVER , May 15, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United ...
- Business Wire
DAVITA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DaVita Inc. - DVA
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into DaVita Inc. (DVA). On December 25, 2016, an article by the New York Times highlighted the relationship between the American Kidney Fund (“AKF”), a charity that helps patients pay for kidney dialysis, and its largest donors, including DaVita, suggesting that the AKF had denied charitable premium assistance (“CPA”) to patients of dialysis companies who did not donate to it.
- ACCESSWIRE
DaVita, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 7, 2019 / DaVita, Inc. (NYSE: DVA ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 7, 2019 at 5:00 PM Eastern Time. To ...
- PR Newswire
DaVita Announces CEO Succession
DENVER, April 29, 2019 /PRNewswire/ -- DaVita Inc. (DVA), a leading provider of kidney care services in the United States and in 10 countries around the world, today announced that its board of directors has unanimously elected Javier J. Rodriguez to succeed Kent Thiry as CEO of DaVita effective June 1, 2019. Rodriguez will also join the DaVita board of directors at that time. Thiry will transition from his current role as chairman and CEO to executive chairman of DaVita's board of directors.
- PR Newswire
DAVITA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DaVita Inc. - DVA
NEW ORLEANS , April 26, 2019 /PRNewswire/ -- Former Attorney General of Louisiana , Charles C. Foti, Jr., Esq. , a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF ...
- PR Newswire
DaVita Inc. Schedules 1st Quarter 2019 Investor Conference Call
DENVER, April 26, 2019 /PRNewswire/ -- DaVita Inc. (DVA), a leading provider of kidney care services in the United States and in 10 countries around the world, announced today that it will hold its quarterly conference call to discuss first quarter results on Tuesday, May 7, 2019, at 5:00 p.m. Eastern Time. This call is also being webcast and can be accessed at the DaVita IR web page. DaVita is a health care provider focused on transforming care delivery to improve quality of life for patients around the globe.
- PR Newswire
DaVita to Use 100 Percent Renewable Energy
DENVER, April 25, 2019 /PRNewswire/ -- By 2022, DaVita Inc. (DVA) expects to use 100 percent renewable energy. The company has contracted with Longroad Energy on two virtual power purchase agreements (PPAs) facilitating the development of clean energy projects in Texas. Together, DaVita's share of these projects will generate as much renewable energy as the amount of electricity used by the company's North American operations.
- PR Newswire
Helping Patients Along Their Kidney Transplant Journey
DENVER, April 24, 2019 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita Inc. (DVA), a leading provider of kidney care services in the United States, today introduced its multi-media kidney transplant education resource, Transplant Smart, which is available to its patients.
- PR Newswire
DaVita Launches Health Tour in California to Provide Health Screenings and Kidney Education
LOS ANGELES , April 23, 2019 /PRNewswire/ -- DaVita Kidney Care , a division of DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States , launches the DaVita Health Tour ...
- ACCESSWIRE
Update in Lawsuit for Investors in shares of Davita Inc (NYSE: DVA) announced by Shareholders Foundation
SAN DIEGO, CA / ACCESSWIRE / April 15, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Davita Inc (NYSE: DVA). Investors who purchased shares ...
- PR Newswire
Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc., Flex Pharma, Inc., MYnd Analytics, Inc., SunCoke Energy Partners, L.P., Top Image Systems Ltd., and Uniti Financial Corporation
NEW YORK , April 5, 2019 /PRNewswire/ -- AmpliPhi Biosciences Corporation (APHB) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of APHB ...
- Business Wire
Robbins Arroyo LLP: Shareholder Class Action Against DaVita Inc. Survives Motion To Dismiss (DVA)
Shareholder rights law firm Robbins Arroyo LLP announces DaVita Inc. may face damages caused by a pending securities lawsuit action lawsuit. DaVita Inc. provides kidney dialysis services.
- GlobeNewswire
Update: Lawsuit for Investors in Davita Inc (NYSE: DVA) shares announced by Shareholders Foundation
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Davita Inc (DVA). Investors who purchased shares of Davita Inc (DVA) in February 2015 or earlier and continue to hold any of those NYSE: DVA shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On February 1, 2017, a lawsuit was filed against Davita Inc over alleged securities laws violations.
- GlobeNewswire
Consolidated Research: 2019 Summary Expectations for Kinder Morgan, DaVita, Inovalon, Switch, Urban Edge Properties, and The Chefs' Warehouse — Fundamental Analysis, Key Performance Indications
NEW YORK, March 28, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.